#Tyme stock price today plus

CDAK fell 14.4% to $1.43 in pre-market trading after the company priced 13.33 million share offering plus accompanying warrants at combined price of $1.50 per share plus warrant. TLF fell 14.5% to $4.01 in pre-market trading.

#Tyme stock price today trial

CRDF shares fell 19.3% to $2.59 in pre-market trading as the company announced plans for a randomized trial, durability of responses in ongoing Phase 1b/2 trial in metastatic colorectal cancer. Credit Suisse downgraded the stock from Outperform to Neutral and lowered the price target from $7 to $4. RENT shares fell 22.9% to $3.80 in pre-market trading after the company reported issued Q3 guidance below estimates and announced a workforce reduction of 24% of corporate employees. NeuroBo Pharmaceuticals shares jumped 101% on Monday after the company announced a 1-for-30 reverse stock split.

NRBO fell 25.3% to $12.46 in pre-market trading. S&P Dow Jones Indices said Catalyst Pharmaceuticals will replace Mantech International Corp. CPRX rose 7% to $16.21 in pre-market trading. JE Cleantech Holdings Limited JCSE rose 7.7% to $1.54 in pre-market trading after gaining over 5% on Monday.SHPH rose 7.8% to $43.32 in pre-market trading amid post-IPO volatility after the stock began trading in late August. Shuttle Pharmaceuticals Holdings, Inc.ACRX rose 9.3% to $0.2747 in pre-market trading after dropping around 10% on Monday. Planet Labs PBC PL rose 11.5% to $6.05 in pre-market trading after the company reported better-than-expected Q2 results and raised guidance.KSPN rose 11.9% to $3.20 in pre-market trading after jumping around 28% on Monday. TYME rose 12.7% to $0.29 in pre-market trading after gaining around 4% on Monday. The Very Good Food Company, last week, announced a review of strategic alternatives. VGFC rose 13.1% to $0.1899 in pre-market trading after declining around 6% on Monday. SEAC shares rose 14.5% to $0.55 in pre-market trading after reporting strong Q2 sales. AREB rose 17.3% to $0.7798 in pre-market trading after surging around 15% on Monday. IBIO rose 18.1% to $0.32 in pre-market trading after declining over 4% on Monday. Zovio Inc ZVO rose 30.3% to $0.3074 in pre-market trading after declining over 5% on Monday.SYRS shares rose 35.6% to $0.9906 in pre-market trading after the FDA granted Syros Pharmaceuticals Orphan Drug Designation for the treatment of pancreatic cancer. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average price of $2.03 - $2.07. CMRA rose 41.7% to $2.72 in pre-market trading.